Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| West Haveni kriteeriumid maksaentsefalopaatia korral× | Harvey-Bradshawi indeks× | |
|---|---|---|
| Valdkond | Gastroenteroloogia | Gastroenteroloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 1966 (original), 1978 (formalized) | 1980 |
| Looja≠ | West Haven Group (Parsons, Williams, Sherlock, Trey, Davidson) | R. F. Harvey and J. M. Bradshaw |
| Tüüp | Clinician-rated | Clinician-rated |
| Algallikas≠ | Parsons, P. L., Williams, R., & Sherlock, S. (1978). The role of plasma amino acids in hepatic encephalopathy and the effect of branched-chain amino acid infusion. Gut, 19(10), 969–978. link ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| Rööpnimetused≠ | Hepatic Encephalopathy Grading, HE Grade, West Haven Grade | HBI |
| Seotud≠ | 4 | 5 |
| Kokkuvõte≠ | The West Haven Criteria are the standard for grading hepatic encephalopathy (HE) severity, ranging from subclinical (Grade 0) to deep coma (Grade 4). Developed by Trey and Davidson in the 1960s and refined by the West Haven group, these criteria integrate mental status changes (confusion, asterixis, disorientation) and consciousness level to stage HE. The West Haven grade is a strong predictor of short-term prognosis in cirrhosis and guides urgency of intervention (lactulose, rifaxomicin, mannitol, intubation). | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGateAndmestik ↗ |
|
|